Treatment of CD30-positive diseases, such as Hodgkin's lymphoma, by administration of a combination of sheddase inhibitor and anti-CD30 immunotherapeutic agents
Hansen, Hinrich P, Engert, AndreasVolume:
18
Language:
english
Journal:
Expert Opinion on Therapeutic Patents
DOI:
10.1517/13543776.18.6.671
Date:
June, 2008
File:
PDF, 423 KB
english, 2008